Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC

Autor: Marcus Scharpf, Jens Bedke, Silvia Ribback, Manuela Gellert, Nils Kroeger, Stefan Winter, Elke Schaeffeler, Matthias Schwab, Viktoria Stühler, Christopher Horst Lillig, Tobias Klatte, Martin Burchardt
Rok vydání: 2021
Předmět:
Zdroj: World journal of urology. 40(3)
ISSN: 1433-8726
Popis: Purpose Thioredoxins are major regulatory proteins of oxidative signaling. Trx1 is the most prominent thioredoxin and, therefore, the current study sought to evaluate the prognostic role of Trx1 in ccRCC. Methods and patients A tissue micro-array (TMA) study was carried out to evaluate the association of Trx1 with clinicopathological features and survival outcome. Data from the Cancer Genome Atlas (TCGA) were evaluated for the association of characteristics in the Trx1 gene with clinicopathological features and survival outcome. Results In the TMA, patients with ccRCC that had high Trx1 levels had lower T stages (p p = 0.018), lower nuclear grades (p p = 0.037) or sarcomatoid features (p = 0.008). Patients with a combined score of ≥ 10 had better DSS than patients with a low combined score of p p = 0.001), and progression free survival (p = 0.001) when compared to patients with ccRCCs without copy number variations (CNV) or gains. Conclusion The current study suggests a possible role of Trx1 in the tumor biology of ccRCC and thus, the current study strongly advises in depth investigations of redox signaling pathways in ccRCC.
Databáze: OpenAIRE